Indocyanine
green (ICG), a near-infrared (NIR) agent with an excellent
imaging performance, has captivated enormous interest from researchers
owing to its excellent therapeutic and imaging abilities. Although
various nanoplatforms-based drug delivery systems (DDS) with the ability
to overcome the clinical limitations of ICG has been reported, ICG-medicated
conventional cancer diagnosis and photorelated therapies still lack
in exhibiting the therapeutic efficacy, resulting in incomplete or
partly tumor elimination. In the view of addressing these concerns,
various DDSs have been engineered for the efficient codelivery of
combined therapeutic agents with ICG, aiming to achieve promising
therapeutic results due to multifunctional imaging-guided synergistic
antitumor effects. In this article, we will systematically review
currently available nanoplatforms based on polymers, inorganic, proteins,
and metal–organic frameworks (MOFs), among others, for codelivery
of ICG along with other therapeutic agents, providing a foundation
for future clinical development of ICG. In addition, codelivery systems
for ICG and different mechanism-based therapeutic agents will be illustrated.
In summary, we conclude the review with the challenges and perspectives
of ICG-based versatile nanoplatforms in detail.